Previously we have reported that in tumor-bearing mice, CD4 depletion with an anti-CD4 depleting antibody (clone: GK5.1) enhances the proliferation of effector CD8+ T cells in the draining lymph node and results in potential anti-tumor immunity [2]. Here, CD8A is linked to neoplasm.